Report Detail

Request for Sample of this report

Pharma & Healthcare Global and China Multivalent Vaccines Market Insights, Forecast to 2026

  • RnM4198550
    • |
  • 10 September, 2020
    • |
  • Global
    • |
  • 145 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Multivalent Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Multivalent Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Multivalent Vaccines market is segmented into
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines

Segment by Application, the Multivalent Vaccines market is segmented into
Pediatrics
Adults

Regional and Country-level Analysis
The Multivalent Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Multivalent Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Multivalent Vaccines Market Share Analysis
Multivalent Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Multivalent Vaccines business, the date to enter into the Multivalent Vaccines market, Multivalent Vaccines product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline, plc (U.K.)
Pfizer, Inc. (U.S.)
Merck & Co., Inc. (U.S.)
Sanofi Pasteur SA (France)
Astellas Pharma Inc. (Japan)
CSL Limited (Australia)
Emergent BioSolutions, Inc. (U.S.)
Johnson & Johnson (U.S.)
MedImmune, LLC (U.S.)
Serum Institute of India Pvt. Ltd. (India)
Bavarian Nordic (Denmark)
Mitsubishi Tanabe Pharma Corporation (Japan)
Daiichi Sankyo (Japan)
Protein Sciences Corporation (U.S.)
Panacea Biotec (India)


1 Study Coverage

  • 1.1 Multivalent Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Multivalent Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Multivalent Vaccines Market Size Growth Rate by Type
    • 1.4.2 Conjugate Vaccines
    • 1.4.3 Inactivated and Subunit Vaccines
    • 1.4.4 Live Attenuated Vaccines
    • 1.4.5 Toxoid Vaccines
    • 1.4.6 Recombinant Vaccines
  • 1.5 Market by Application
    • 1.5.1 Global Multivalent Vaccines Market Size Growth Rate by Application
    • 1.5.2 Pediatrics
    • 1.5.3 Adults
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Multivalent Vaccines Market Size, Estimates and Forecasts
    • 2.1.1 Global Multivalent Vaccines Revenue 2015-2026
    • 2.1.2 Global Multivalent Vaccines Sales 2015-2026
  • 2.2 Global Multivalent Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Multivalent Vaccines Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Multivalent Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Multivalent Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Multivalent Vaccines Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Multivalent Vaccines Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Multivalent Vaccines Revenue Forecast by Region (2021-2026)

3 Global Multivalent Vaccines Competitor Landscape by Players

  • 3.1 Global Top Multivalent Vaccines Sales by Manufacturers
    • 3.1.1 Global Multivalent Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Multivalent Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Multivalent Vaccines Manufacturers by Revenue
    • 3.2.1 Global Multivalent Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Multivalent Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Multivalent Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Multivalent Vaccines Revenue in 2019
    • 3.2.5 Global Multivalent Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Multivalent Vaccines Price by Manufacturers
  • 3.4 Global Multivalent Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 Multivalent Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Multivalent Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into Multivalent Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Multivalent Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global Multivalent Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global Multivalent Vaccines Revenue by Type (2015-2020)
    • 4.1.3 Multivalent Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Multivalent Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Multivalent Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Multivalent Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 Multivalent Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Multivalent Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Multivalent Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global Multivalent Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global Multivalent Vaccines Revenue by Application (2015-2020)
    • 5.1.3 Multivalent Vaccines Price by Application (2015-2020)
  • 5.2 Multivalent Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Multivalent Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Multivalent Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Multivalent Vaccines Price Forecast by Application (2021-2026)

6 China by Players, Type and Application

  • 6.1 China Multivalent Vaccines Market Size YoY Growth 2015-2026
    • 6.1.1 China Multivalent Vaccines Sales YoY Growth 2015-2026
    • 6.1.2 China Multivalent Vaccines Revenue YoY Growth 2015-2026
    • 6.1.3 China Multivalent Vaccines Market Share in Global Market 2015-2026
  • 6.2 China Multivalent Vaccines Market Size by Players (International and Local Players)
    • 6.2.1 China Top Multivalent Vaccines Players by Sales (2015-2020)
    • 6.2.2 China Top Multivalent Vaccines Players by Revenue (2015-2020)
  • 6.3 China Multivalent Vaccines Historic Market Review by Type (2015-2020)
    • 6.3.1 China Multivalent Vaccines Sales Market Share by Type (2015-2020)
    • 6.3.2 China Multivalent Vaccines Revenue Market Share by Type (2015-2020)
    • 6.3.3 China Multivalent Vaccines Price by Type (2015-2020)
  • 6.4 China Multivalent Vaccines Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 China Multivalent Vaccines Sales Forecast by Type (2021-2026)
    • 6.4.2 China Multivalent Vaccines Revenue Forecast by Type (2021-2026)
    • 6.4.3 China Multivalent Vaccines Price Forecast by Type (2021-2026)
  • 6.5 China Multivalent Vaccines Historic Market Review by Application (2015-2020)
    • 6.5.1 China Multivalent Vaccines Sales Market Share by Application (2015-2020)
    • 6.5.2 China Multivalent Vaccines Revenue Market Share by Application (2015-2020)
    • 6.5.3 China Multivalent Vaccines Price by Application (2015-2020)
  • 6.6 China Multivalent Vaccines Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 China Multivalent Vaccines Sales Forecast by Application (2021-2026)
    • 6.6.2 China Multivalent Vaccines Revenue Forecast by Application (2021-2026)
    • 6.6.3 China Multivalent Vaccines Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Multivalent Vaccines Market Size YoY Growth 2015-2026
  • 7.2 North America Multivalent Vaccines Market Facts & Figures by Country
    • 7.2.1 North America Multivalent Vaccines Sales by Country (2015-2020)
    • 7.2.2 North America Multivalent Vaccines Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Multivalent Vaccines Market Size YoY Growth 2015-2026
  • 8.2 Europe Multivalent Vaccines Market Facts & Figures by Country
    • 8.2.1 Europe Multivalent Vaccines Sales by Country
    • 8.2.2 Europe Multivalent Vaccines Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Multivalent Vaccines Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Multivalent Vaccines Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Multivalent Vaccines Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Multivalent Vaccines Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Multivalent Vaccines Market Size YoY Growth 2015-2026
  • 10.2 Latin America Multivalent Vaccines Market Facts & Figures by Country
    • 10.2.1 Latin America Multivalent Vaccines Sales by Country
    • 10.2.2 Latin America Multivalent Vaccines Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Multivalent Vaccines Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Multivalent Vaccines Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Multivalent Vaccines Sales by Country
    • 11.2.2 Middle East and Africa Multivalent Vaccines Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 GlaxoSmithKline, plc (U.K.)
    • 12.1.1 GlaxoSmithKline, plc (U.K.) Corporation Information
    • 12.1.2 GlaxoSmithKline, plc (U.K.) Description and Business Overview
    • 12.1.3 GlaxoSmithKline, plc (U.K.) Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Products Offered
    • 12.1.5 GlaxoSmithKline, plc (U.K.) Recent Development
  • 12.2 Pfizer, Inc. (U.S.)
    • 12.2.1 Pfizer, Inc. (U.S.) Corporation Information
    • 12.2.2 Pfizer, Inc. (U.S.) Description and Business Overview
    • 12.2.3 Pfizer, Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Pfizer, Inc. (U.S.) Multivalent Vaccines Products Offered
    • 12.2.5 Pfizer, Inc. (U.S.) Recent Development
  • 12.3 Merck & Co., Inc. (U.S.)
    • 12.3.1 Merck & Co., Inc. (U.S.) Corporation Information
    • 12.3.2 Merck & Co., Inc. (U.S.) Description and Business Overview
    • 12.3.3 Merck & Co., Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Merck & Co., Inc. (U.S.) Multivalent Vaccines Products Offered
    • 12.3.5 Merck & Co., Inc. (U.S.) Recent Development
  • 12.4 Sanofi Pasteur SA (France)
    • 12.4.1 Sanofi Pasteur SA (France) Corporation Information
    • 12.4.2 Sanofi Pasteur SA (France) Description and Business Overview
    • 12.4.3 Sanofi Pasteur SA (France) Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Sanofi Pasteur SA (France) Multivalent Vaccines Products Offered
    • 12.4.5 Sanofi Pasteur SA (France) Recent Development
  • 12.5 Astellas Pharma Inc. (Japan)
    • 12.5.1 Astellas Pharma Inc. (Japan) Corporation Information
    • 12.5.2 Astellas Pharma Inc. (Japan) Description and Business Overview
    • 12.5.3 Astellas Pharma Inc. (Japan) Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Astellas Pharma Inc. (Japan) Multivalent Vaccines Products Offered
    • 12.5.5 Astellas Pharma Inc. (Japan) Recent Development
  • 12.6 CSL Limited (Australia)
    • 12.6.1 CSL Limited (Australia) Corporation Information
    • 12.6.2 CSL Limited (Australia) Description and Business Overview
    • 12.6.3 CSL Limited (Australia) Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 CSL Limited (Australia) Multivalent Vaccines Products Offered
    • 12.6.5 CSL Limited (Australia) Recent Development
  • 12.7 Emergent BioSolutions, Inc. (U.S.)
    • 12.7.1 Emergent BioSolutions, Inc. (U.S.) Corporation Information
    • 12.7.2 Emergent BioSolutions, Inc. (U.S.) Description and Business Overview
    • 12.7.3 Emergent BioSolutions, Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Products Offered
    • 12.7.5 Emergent BioSolutions, Inc. (U.S.) Recent Development
  • 12.8 Johnson & Johnson (U.S.)
    • 12.8.1 Johnson & Johnson (U.S.) Corporation Information
    • 12.8.2 Johnson & Johnson (U.S.) Description and Business Overview
    • 12.8.3 Johnson & Johnson (U.S.) Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Johnson & Johnson (U.S.) Multivalent Vaccines Products Offered
    • 12.8.5 Johnson & Johnson (U.S.) Recent Development
  • 12.9 MedImmune, LLC (U.S.)
    • 12.9.1 MedImmune, LLC (U.S.) Corporation Information
    • 12.9.2 MedImmune, LLC (U.S.) Description and Business Overview
    • 12.9.3 MedImmune, LLC (U.S.) Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 MedImmune, LLC (U.S.) Multivalent Vaccines Products Offered
    • 12.9.5 MedImmune, LLC (U.S.) Recent Development
  • 12.10 Serum Institute of India Pvt. Ltd. (India)
    • 12.10.1 Serum Institute of India Pvt. Ltd. (India) Corporation Information
    • 12.10.2 Serum Institute of India Pvt. Ltd. (India) Description and Business Overview
    • 12.10.3 Serum Institute of India Pvt. Ltd. (India) Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Products Offered
    • 12.10.5 Serum Institute of India Pvt. Ltd. (India) Recent Development
  • 12.11 GlaxoSmithKline, plc (U.K.)
    • 12.11.1 GlaxoSmithKline, plc (U.K.) Corporation Information
    • 12.11.2 GlaxoSmithKline, plc (U.K.) Description and Business Overview
    • 12.11.3 GlaxoSmithKline, plc (U.K.) Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Products Offered
    • 12.11.5 GlaxoSmithKline, plc (U.K.) Recent Development
  • 12.12 Mitsubishi Tanabe Pharma Corporation (Japan)
    • 12.12.1 Mitsubishi Tanabe Pharma Corporation (Japan) Corporation Information
    • 12.12.2 Mitsubishi Tanabe Pharma Corporation (Japan) Description and Business Overview
    • 12.12.3 Mitsubishi Tanabe Pharma Corporation (Japan) Sales, Revenue and Gross Margin (2015-2020)
    • 12.12.4 Mitsubishi Tanabe Pharma Corporation (Japan) Products Offered
    • 12.12.5 Mitsubishi Tanabe Pharma Corporation (Japan) Recent Development
  • 12.13 Daiichi Sankyo (Japan)
    • 12.13.1 Daiichi Sankyo (Japan) Corporation Information
    • 12.13.2 Daiichi Sankyo (Japan) Description and Business Overview
    • 12.13.3 Daiichi Sankyo (Japan) Sales, Revenue and Gross Margin (2015-2020)
    • 12.13.4 Daiichi Sankyo (Japan) Products Offered
    • 12.13.5 Daiichi Sankyo (Japan) Recent Development
  • 12.14 Protein Sciences Corporation (U.S.)
    • 12.14.1 Protein Sciences Corporation (U.S.) Corporation Information
    • 12.14.2 Protein Sciences Corporation (U.S.) Description and Business Overview
    • 12.14.3 Protein Sciences Corporation (U.S.) Sales, Revenue and Gross Margin (2015-2020)
    • 12.14.4 Protein Sciences Corporation (U.S.) Products Offered
    • 12.14.5 Protein Sciences Corporation (U.S.) Recent Development
  • 12.15 Panacea Biotec (India)
    • 12.15.1 Panacea Biotec (India) Corporation Information
    • 12.15.2 Panacea Biotec (India) Description and Business Overview
    • 12.15.3 Panacea Biotec (India) Sales, Revenue and Gross Margin (2015-2020)
    • 12.15.4 Panacea Biotec (India) Products Offered
    • 12.15.5 Panacea Biotec (India) Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Multivalent Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Multivalent Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Multivalent Vaccines. Industry analysis & Market Report on Multivalent Vaccines is a syndicated market report, published as Global and China Multivalent Vaccines Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Multivalent Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,014.70
    		4,522.05
    		6,029.40
    		3,595.80
    		5,393.70
    		7,191.60
    		595,764.00
    		893,646.00
    		1,191,528.00
    		328,029.00
    		492,043.50
    		656,058.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo